AOCI at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s AOCI?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported AOCI of $466K in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s AOCI changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s AOCI increased by 43.8% year-over-year, from $324K to $466K.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s AOCI?
- Over 3 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s AOCI has grown at a 128.4% compound annual growth rate (CAGR), from -$44K to $524K.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.